Search the Newsreel

Tema ETFs LLC Increases Stock Position in Amgen Inc. $AMGN

Tema ETFs LLC significantly increased its stake in Amgen Inc. by 14.5% during the second quarter, bringing its total holdings to 26,231 shares valued at approximately $9.5 million. This move comes as Amgen reported strong Q2 earnings, beating analyst estimates with EPS of $6.29 …

G&S Capital LLC Makes New $1.58 Million Investment in Amgen Inc. $AMGN

G&S Capital LLC has made a new $1.58 million investment in Amgen Inc. by purchasing 4,359 shares in the second quarter. The medical research company recently exceeded quarterly earnings and revenue expectations, reporting $6.29 EPS and $10.05 billion in revenue. Amgen also declared a …

AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD

Amgen (NASDAQ: AMGN) announced its plan to open a new Science and Innovation Center in Genome Valley, Hyderabad, expanding its global R&D network. This new center aims to integrate experimental science with data and technology to accelerate the discovery and development of innovative medicines. …

IAMGOLD (IAG) nets $70M and royalty in Bambadji joint venture sale

IAMGOLD Corporation has completed the sale of its indirect 35% interest in the Bambadji Joint Venture in Senegal to Fortuna Mining Corp. for approximately $70 million in cash, before taxes and transaction costs. This divestiture monetizes a non-core exploration asset, allowing IAMGOLD to focus …

Handelsbanken Fonder AB Has $125.51 Million Stake in Amgen Inc. $AMGN

Handelsbanken Fonder AB increased its stake in Amgen Inc. by 15.7% in the second quarter, now owning 346,596 shares valued at $125.51 million. Several other institutional investors also adjusted their positions in Amgen. The article also provides financial details, recent earnings, dividend information, and …

Amgen Inc. $AMGN Shares Acquired by KMG Fiduciary Partners LLC

KMG Fiduciary Partners LLC increased its stake in Amgen Inc. by 38.9% in the second quarter, bringing its total holdings to 9,856 shares valued at $3.57 million. Institutional investors now own 76.5% of Amgen's stock. The company recently beat earnings expectations, reporting $6.29 EPS …

Fortuna to buy Bambadji gold project in Senegal from Barrick, IAMGOLD (NYSE:FSM)

Fortuna Mining (FSM) has announced an agreement to acquire the Bambadji advanced gold exploration project in Senegal from Barrick Mining (B) and IAMGOLD (IAG) for $200 million in cash. Barrick will receive $130.35 million and IAMGOLD will receive $69.65 million from the transaction. The …

Amgen (AMGN) director Charles Holley receives stock award and reports trust holdings

Amgen director Charles M. Holley reported receiving a compensation-related grant of 103.4189 shares of common stock on August 7, 2026. Following this award, he directly holds 12,990.4520 shares, which include Dividend Equivalents, and indirectly holds 1,260.0000 shares through the Holley Family Trust. This transaction …

Amgen (AMGN) director Michael V. Drake granted 63.8764 shares in equity award

Amgen director Michael V. Drake was granted 63.8764 shares of common stock as compensation on August 7, 2026. This automatic award, valued at $0.00 per share, increases his direct holdings to 5,876.1633 shares, which includes 377 Dividend Equivalents linked to unvested Restricted Stock Units. …

IAMGOLD completes sale of Senegal stake for $70 million

IAMGOLD Corporation has finalized the sale of its 35% interest in the Bambadji Joint Venture and an associated exploration permit in Senegal to Fortuna Mining Corp. The transaction generated approximately $70 million in cash proceeds for IAMGOLD before taxes and transaction costs. The company …

IAMGOLD Announces Closing of Sale of Its Interest in the Bambadji Joint Venture in Senegal

All monetary amounts are expressed in U.S. dollars, unless otherwise indicated. Toronto, Ontario--(Newsfile Corp. - August 10, 2026) - IAMGOLD Corporation (TSX: IMG) (NYSE: IAG) ("IAMGOLD" or the "Company") today announced the completion of the sale of its indirect 35% interest in the Bambadji …

National Bank Financial Issues Positive Forecast for IAMGOLD (TSE:IMG) Stock Price

Amgen Inc. stock outperforms competitors on strong trading day

Amgen Inc. stock (AMGN) rose 1.52% to $417.20 on Monday, outperforming the broader market during a challenging trading session. This marks the stock's second consecutive day of gains, contrasting with slight declines in the S&P 500 and Dow Jones Industrial Average.

Iamgold Corp. Price Target Raised to C$32.00/Share From C$31.00 by National Bank

National Bank has increased its price target for Iamgold Corp. to C$32.00 per share, up from the previous C$31.00. This adjustment was reported by Dow Jones and sourced from Baystreet.ca, indicating a positive outlook from the analyst firm.

Are Investors Undervaluing Affiliated Managers Group (AMG) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Guggenheim raises Amgen stock price target to $388 on strong quarter

Guggenheim has increased its price target for Amgen Inc. (NASDAQ:AMGN) to $388 from $343, maintaining a Neutral rating after the company's strong second-quarter 2026 earnings. Amgen surpassed both Guggenheim's and consensus expectations, leading to revised fiscal year 2026 revenue and EPS estimates. Despite the …

Amgen Inc. (AMGN) Stock Analysis: Navigating a Strong Market Cap with High Return on Equity

Amgen Inc. (AMGN) is a significant player in the healthcare sector with a market capitalization of $221.79 billion. The company boasts a strong financial position, evidenced by its forward P/E ratio of 17.03, a remarkable return on equity of 91.47%, and robust free cash …

AMGEN INC : HSBC RAISES TARGET PRICE TO $445 FROM $425

HSBC has increased its target price for Amgen Inc. shares to $445, up from the previous $425. This adjustment reflects a positive outlook from the banking giant on the pharmaceutical company's stock.

Amundi Trims Stake in Affiliated Managers Group, Inc. $AMG

Erste Group Bank Brokers Lower Earnings Estimates for Amgen

Erste Group Bank has lowered its FY2027 EPS estimate for Amgen to $23.50 from $23.58, while maintaining a "Hold" rating on the stock. This revised estimate still remains above the current full-year consensus of $22.78. Amgen reported strong Q2 results, with EPS of $6.29 …

Is IAMGOLD (TSX:IMG) Still Cheap After Its Strong Q2 Update?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. IAMGOLD stock has logged a very strong multi year return, yet the current intrinsic value estimates based on a Discounted Cash Flow (DCF) approach still point to …

Amgen Inc. (AMGN) Stock forecasts

Amgen, a leader in biotechnology, is experiencing broad-based growth despite biosimilar competition for Prolia, leading Morningstar to maintain its fair value assessment. The company's flagship drugs include Epogen, Aranesp, Neupogen, Neulasta, Enbrel, Otezla, and its first cancer therapeutic, Vectibix. The current stock price is …

IAMGOLD (TSX:IMG) Could Be 18% Undervalued As Strong Q2 Results Lift Interest

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. IAMGOLD (TSX:IMG) has moved into focus after reporting second quarter 2026 results that featured …

Oliver Luxxe Assets LLC Sells 2,757 Shares of Affiliated Managers Group, Inc. $AMG

Oliver Luxxe Assets LLC reduced its stake in Affiliated Managers Group (AMG) by 21% in the second quarter, selling 2,757 shares and retaining 10,344 shares valued at approximately $3.5 million. Despite this, institutional investors and hedge funds still own 95.3% of AMG, and analysts …

IAMGOLD (TSX:IMG) Is Up 28.8% After Strong Q2, Big Buybacks And Board Refresh – What’s Changed

In the second quarter of 2026, IAMGOLD Corporation reported higher sales of US$856.9 million and net income of US$230.5 million year over year, completed a share repurchase of 28,000,000 shares for CA$510.4 million since December 2025, and earlier appointed veteran mining executive Catherine McLeod-Seltzer …

Avity Investment Management Inc. Has $27.59 Million Stock Holdings in Amgen Inc. $AMGN

Avity Investment Management Inc. significantly increased its stake in Amgen Inc. by 5.3% in the second quarter, bringing its total holdings to 76,186 shares valued at approximately $27.59 million. Amgen recently reported strong second-quarter results, exceeding revenue and EPS expectations, and raised its 2026 …

Cardano Risk Management B.V. Sells 14,358 Shares of Amgen Inc. $AMGN

Cardano Risk Management B.V. has reduced its stake in Amgen Inc. by 5.2%, selling 14,358 shares and retaining 260,359 shares valued at $94.3 million. Amgen reported strong Q2 2026 results, exceeding revenue and EPS expectations, and raised its full-year earnings guidance despite discontinuing an …

Iamgold (NYSE:IAG) Announces Earnings Results

Amgen (AMGN) Stock Sees Fair Value Lift After Q2 Beat And Analyst Target Hikes

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Amgen is back in focus after updated valuation work lifted its modeled fair value from US$352.23 to US$371.93 per share, signaling a higher …

Amgen Inc. Stock 12‑Month Price Target Raised to $378.67, Implies 6% Downside

Amgen Inc.'s average stock price target has been raised to $378.67 by 27 analysts, up from $376.44. This updated target implies a 6% potential downside based on the August 6 closing price. Despite the potential downside, the consensus rating from 35 analysts remains at …

Iamgold Q2 Earnings Call Highlights

Key Points Interested in Iamgold Corporation? Here are five stocks we like better. IAMGOLD remains on track for 2026 production guidance of 720,000–820,000 ounces after producing 188,100 attributable ounces in Q2 and 371,700 ounces in the first half. Strong results generated $445.1 million in …

Amgen (AMGN) Is Up 6.7% After EMA Backs Broader Repatha Use in High-Risk Patients – Has The Bull Case Changed?

Amgen's stock rose 6.7% after the European Medicines Agency's CHMP supported broader use of its drug Repatha for high-risk atherosclerotic cardiovascular disease patients in Europe. This potential expansion, driven by positive Phase 3 trial data, could significantly increase Repatha's eligible patient base. While strengthening …

Bank of America Corp DE Acquires 176,246 Shares of Affiliated Managers Group, Inc. $AMG

Bank of America Corp DE significantly increased its stake in Affiliated Managers Group, Inc. (AMG) by 75.5% in the first quarter, acquiring 176,246 additional shares and bringing its total holdings to 409,578 shares valued at $113.3 million. This move comes as AMG reported strong …

Assenagon Asset Management S.A. Has $69.25 Million Position in Amgen Inc. $AMGN

Assenagon Asset Management S.A. significantly reduced its stake in Amgen Inc. by 44.5% during the second quarter, now holding 191,247 shares valued at $69.25 million. Despite this, other institutional investors have increased their positions, and analysts have set new price targets, with a consensus …

Iamgold (NYSE:IAG) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen has downgraded Iamgold (NYSE:IAG) to a "Hold" rating, moving it from a "Buy." Despite this, the broader analyst consensus for Iamgold remains a "Moderate Buy" with an average price target of $19.00. The company reported quarterly EPS of $0.42, matching estimates, …

IAMGOLD Corporation (NYSE: IAG) lifts Q2 2026 cash, cuts debt and buys back shares

IAMGOLD Corporation announced strong Q2 2026 results, reporting increased revenues, net earnings, and adjusted EBITDA, driven by higher gold prices and production. The company strengthened its balance sheet by fully repaying its credit facility, repurchasing 8.6 million shares for $147.9 million, and increasing liquidity …